5-HT4 receptors are not involved in the control of small intestinal transit in the fasted conscious rat

Neurogastroenterology and Motility

Volumn 8, Issue 1, 1996, Pages 1-8

  Clayton, N M ^a   Gale, J D ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 HT4 receptors; Benzamides; GR125487; Small intestinal transit

Indexed keywords

5 FLUORO 2 METHOXY 1H INDOLE 3 CARBOXYLIC ACID 1 [2 (METHYLSULFONAMIDO)ETHYL] 4 PIPERIDINYLMETHYL ESTER; ACETYLCHOLINE; ATROPINE; BETHANECHOL; CISAPRIDE; CLONIDINE; METOCLOPRAMIDE; RADIOACTIVE MICROSPHERE; SEROTONIN 4 RECEPTOR; UNCLASSIFIED DRUG; ZACOPRIDE; MICROSPHERE; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

ACETYLCHOLINE RELEASE; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; DUODENUM; GASTROESOPHAGEAL REFLUX; INTESTINE MOTILITY; MALE; MYENTERIC PLEXUS; NONHUMAN; PRIORITY JOURNAL; RAT; SMALL INTESTINE; ANIMAL; DIET RESTRICTION; DRUG EFFECT; GASTROINTESTINAL TRANSIT; PHYSIOLOGY; RAT STRAIN;

ANIMALS; FASTING; GASTROINTESTINAL TRANSIT; INTESTINE, SMALL; MALE; MICROSPHERES; RATS; RATS, INBRED STRAINS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS;

EID: 0029670747     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2982.1996.tb00236.x     Document Type: Article

References (45)

1. Jacoby HT, Brodie A. Biointestinal actions of metoclopramide. Gastroenterology 1967; 52:676-83.
2. Decktor DL, Pendleton RG, Elnitosky AT, Jenkins AM and McDowell AP. Effect of metoclopramide, bethanechol and the cholecystokinin receptor antagonist, L-364,718 on gastric emptying in the rat. Eur J Pharmacol 1988; 147:313-6.
3. 3 antagonist. Drug Develop Res 1992; 26:405-17.
4. Megens A, Canters LLJ, Antosis SK, Smeyers F, Keersmaekers RCA, Awouters F. Non-antidopaminergic, non-cholinergic stimulation of gastric emptying with cisapride (R51619) in rats. Drug Develop Res 1986;9:243-50.
5. Droppleman DA, Gregory RJ, Alphin RS. A simplified method for assessing drug effects on gastric emptying in rats. J Pharmacol Meth 1980; 4:227-30.
6. Wiseman LR, Faulds D. Cisapride: an update review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders. Drugs 1994; 47:116-52.
7. Fink SM, Lange RC, McCallum RW. Effect of metoclopramide on normal and delayed gastric emptying in gastrooesophageal reflux patients. Dig Dis Sci 1983; 28:1057-61.
8. Reyntjens A, Verlinden M, Aerts T. Development and clinical use of the gastrointestinal prokinetic drug cisapride (R51619). Drug Develop Res 1986; 8:251-65.
9. McCallum RW, Prakash C, Campoli-Richardson DM, Goa KL. Cisapride: a preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use as a prokinetic agent in gastrointestinal motility disorders. Drugs 1988; 36:652-81.
10. Camilleri M, Malagelada JR, Abeli TL, Brown ML, Hench V, Zinsmeister AR. Effect of six weeks on treatment with cisapride in gastroparesis and intestinal pseudoobstruction. Gastroenterology 1989; 96:704-12.
11. Tollesson PO, Rimback G, Gascen A, Bergman L, Mattsson E. Treatment of postoperative paralytic ileus with cisapride. Scand J Gastroenterol 1991; 26:477-82.
12. 3 receptor antagonists. Drug Design and Delivery 1988; 3:273-95.
13. 4 receptor. Med Res Rev 1993; 13:633-62.
14. 4 receptor and gastrointestinal prokinetic action. Pharmacol Res 1991; 24:5-14.
15. 4 receptors mediate inhibition and facilitation of fast synaptic transmission in enteric neurons. Am J Physiol 1994; 266:G230-8.
16. Reeves JJ, Bunce KT, Humphrey PPA. Investigation into the 5-hydroxytryptamine receptor mediating smooth muscle relaxation in the rat oesophagus. Br J Pharmacol 1991; 103:1067-72.
17. 4 receptor stimulation on basal and electrically evoked release of acetylcholine from guinea-pig myenteric pleus. Naunyn-Schmiedeberg's Arch Pharmacol 1992; 345:270-5.
18. Tonini M, Galligan JJ, North RA. Effects of cisapride on cholinergic neurotransmission and propulsive motility in the guinea-pig ileum. Gastroenterol 1989; 96:1257-64.
19. 4 receptor activation. Br J Pharmacol 1991; 102:563-4.
20. 4 receptor antagonist. J Gastrointest Mot 1993; 5: 192.
21. 4 receptor antagonist. Br J Pharmacol 113-20P.
22. Miller MS, Galligan JJ, Burks TF. Accurate measurement of intestinal transit in the rat. J Pharmacol Meth 1981; 211-17.
23. Ruwart MJ, Klepper MS, Rush BD. Evidence for non cholinergic mediation of small intestinal transit in the rat. J Pharmacol Exp Ther 1979; 229:462-5.
24. Hsu WW, McNeel SV. Effect of yohimbine on xylasine-induced prolongation of gastrointestinal transit in dogs. J Am Med Assoc 1983; 183:297-300.
25. 2 infusion. Prostaglandins Leukot Med 1982; 9:629-40.
26. Fiocchi R, Bianchi G, Petrillo A, Tavani A, Manava L. Morphine inhibits gastrointestinal transit in the rat primarily in impairing propulsive activity of the small intestine. Life Sci 1982; 31:2221-3.
27. Ruwart MJ, Klepper MS, Rush RD. Clonidine delays small intestinal transit in the rat. J Pharmacol Exp Ther 1980; 212:487-90.
28. Tadano T, Kisara K, Stewart JJ. A comparison of peripheral and central effects of clonidine on rat intestinal transit. Res Comm Chem Pathol Pharm 1992; 78:161-79.
29. 3H] para-amino clonidine: a novel ligand which binds with high affinity to α-adrenergic receptors. Life Sci 1979; 25:769-74.
30. Leclerc G, Rouot B, Schwartz J, Velly J, Wermuth CG. Studies on some para-substituted clonidine derivatives that exhibit an α-adrenoceptor stimulant activity. Br J Pharmacol 1980; 71:5-9.
31. 2 receptors are involved in the control of small intestinal transit time in the rat. Pharmacol Res 1992; 26:179-85.
32. Brown NJ, Horton A, Rumsey RD, Read NW. Granisetron and ondansetron: effects on the ileal brake mechanism in the rat. J Pharm Pharmacol 1993; 45:521-4.
33. Talley NJ. Review article 5-hydroxytryptamine agonist and antagonists in the modulation of gastrointestinal motility and sensation: clinical implication. Aliment Pharmacol Ther 1992; 6:273-89.
34. Mawe GM, Branchek TA, Gershon MD. Peripheral neural serotonin receptors: identification and characterisation with specific antagonists and agonists. Proc Natl Acad Sci USA 1985; 83:9799-803.
35. 4 binding site in rodent brain. Neuropharmacol 1994; 33:537-41.
36. Eleasson, S. Central control of digestive function. In: Field J, ed. in chief. Handbook of Physiology, Volume 11, Sect. 1. Washington DC: American Physiological Society, 1960: 1163-72.
37. Costal B, Gunning SJ, Naylor RJ. An analysis of the hypothalamic sites at which substituted benzamide drugs act to facilitate gastric emptying in the guinea-pig. Neuropharm, 1985; 24: 869-75.
38. Grundy, D. Extrinsic innervation. In: Gastrointestinal motility. The integration of physiological mechanisms. MTP Press Ltd, 1985; 35-56.
39. Costal B, Naylor RJ. Neuropharmacology of emesis in relation to clinical response. Br J Cancer Suppl, 1992; 19:52-7.
40. Reyntjens A, Verlunden M, Aerts T. Development and clinical use of the new gastrointestinal prokinetic drug cisapride R51619. Drug Develop Res 1986; 8:251-65.
41. Tollesson PO, Cassuto J, Rimback G, Faxen A, Bergman L, Mettsson E. Treatment of postoperative ileus with cisapride. Scand J Gastroenterol 1991; 26:477-82.
42. Evans PR, Kellow JE, Bak YT, Jones MP. Effects of cisapride on small bowel motility in irritable bowel syndrome (IBS). Abstract Gastroenterol 1993; 104:A504.
43. Hurlimann S, Sharron P, Misieiowz JJ. Effects of cisapride on symptoms and ileo-caecal transit in patients with bloated irritable bowel syndrome. Abstract Gastroenterol 1992, 102 (Suppl.).
44. Van Outryve M, Milo R, Toussant J, Van Eegham, P. Prokinetic treatment of constipation-predominant irritable bowel syndrome. A placebo-controlled study of cisapride. J Clinical Gastroenterol 1991; 13:49-57.
45. Lysgard Madsen J. Effect of cisapride on gastrointestinal transit in healthy humans. Dig Dis Sci 1990; 35:1500-4.